Lower Dose of rhBMP-2 Achieves Spine Fusion When Combined With an Osteoconductive Bulking Agent in Non-human Primates
暂无分享,去创建一个
B. Barnes | A. Minamide | S. Boden | Jin-soo Park | M. Park | Bryan Barnes | Scott D Boden | John Louis-Ugbo | Patrick R Tomak | Jin-Soo Park | Moon-Soo Park | Akihito Minamide | P. Tomak | John Louis-Ugbo
[1] E. Carragee. Single-Level Posterolateral Arthrodesis, with or without Posterior Decompression, for the Treatment of Isthmic Spondylolisthesis in Adults. A Prospective, Randomized Study* , 1997, The Journal of bone and joint surgery. American volume.
[2] L. Titus,et al. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.
[3] H. Chambers,et al. Complications of iliac crest bone graft harvesting. , 1996, Clinical orthopaedics and related research.
[4] S. Stralka,et al. A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. , 2003, Orthopedics.
[5] J. Michael Kabo,et al. Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.
[6] H. Sandhu. Anterior lumbar interbody fusion with osteoinductive growth factors. , 2000, Clinical orthopaedics and related research.
[7] S. Boden,et al. The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.
[8] W C Lauerman,et al. A randomized prospective study of posterolateral lumbar fusion. Outcomes with and without pedicle screw instrumentation. , 1999, Spine.
[9] J. Goulet,et al. Autogenous Iliac Crest Bone Graft: Complications and Functional Assessment , 1997, Clinical orthopaedics and related research.
[10] M. Marone,et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.
[11] S. Boden. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. , 2000, Tissue engineering.
[12] J. Wozney,et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.
[13] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[14] R. Mcguire,et al. The Use of Primary Internal Fixation in Spondylolisthesis , 1993, Spine.
[15] H. Shingu,et al. Lumbar posterolateral fusion alone or with transpedicular instrumentation in L4--L5 degenerative spondylolisthesis. , 2001, Journal of spinal disorders.
[16] Marc A. Asher,et al. Iliac Crest Bone Graft Harvest Donor Site Morbidity: A Statistical Evaluation , 1995, Spine.
[17] Banwart Jc,et al. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. , 1995 .
[18] S. Boden,et al. Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.
[19] Hak-Sun Kim,et al. Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine Fusion , 2003, Spine.
[20] W C Hutton,et al. The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part II Study of Dose, Carrier, and Species , 1995, Spine.
[21] W. Hutton,et al. Delivery of Recombinant Human Bone Morphogenetic Protein-2 Using a Compression-Resistant Matrix in Posterolateral Spine Fusion in the Rabbit and in the Non-Human Primate , 2002, Spine.
[22] H N Herkowitz,et al. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. , 1991, The Journal of bone and joint surgery. American volume.
[23] W. Hutton,et al. The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part I Biolog of Spinal Fusion , 1995 .
[24] S. Boden. Bioactive factors for bone tissue engineering. , 1999, Clinical orthopaedics and related research.
[25] L. Lenke,et al. The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. , 1993, Journal of spinal disorders.
[26] M. Mackay,et al. 1997 Volvo Award Winner in Clinical Studies: Degenerative Lumbar Spondylolisthesis With Spinal Stenosis: A Prospective, Randomized Study Comparing Decompressive Laminectomy and Arthrodesis With and Without Spinal Instrumentation , 1997, Spine.
[27] L. Lenke,et al. Minimum 5-year results of degenerative spondylolisthesis treated with decompression and instrumented posterior fusion. , 1999, Spine.
[28] Serena S. Hu,et al. Patient outcomes after decompression and instrumented posterior spinal fusion for degenerative spondylolisthesis. , 1999, Spine.
[29] S. Boden,et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.